Clinical Trial Update: Trial of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) in Older Patients With Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pentostatin, cyclophosphamide, and ofatumumab (PCO) in older patients with chronic lymphocytic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Ofatumumab (Arzerra) (Ofatumumab)
• Pentostatin (pentostatin)

Snippet

Sponsor: Niguarda Hospital | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED